Translational Research

Translational Research in Oncology (TRIO) is a global, not-for-profit clinical research organization (CRO) that specializes in the design and management of oncology clinical trials. Founded in 1997, the organization bridges the gap between academic research and pharmaceutical development by leveraging a worldwide network of investigators and scientific leaders. TRIO provides full-service clinical trial management, from study conception and design to data analysis and regulatory submission. The company is particularly well-known for its expertise in breast cancer research and has played a pivotal role in the registration trials of several major oncology therapies. With operations spanning North America, Europe, and Asia, TRIO focuses on delivering high-quality, biologically sound clinical data to accelerate the availability of innovative cancer treatments.